Bioactivity protected new ashwagandha extract

Arjuna will feature Shoden, its potent, all-natural, bioactivity confirmed extract of ashwagandha (Withania somnifera) at Hi Europe 2018

Shoden contains ashwagandha extract standardised with 35% withanolide glycosides, a highly active component of ashwagandha.

Shoden is manufactured from carefully selected shwagandha roots and leaves.

Toxins are removed from the roots and leaves using a proprietary detoxification process that also removes other undesirable components and maintains withanolide glycosides at optimum levels.

Arjuna (Booth 8F83) developed its Bioactive Ingredient Protection System (BIPS) proprietary safety technology to ensure optimal delivery of the bioactive components of ashwagandha.

BIPS is a patented procedure in which all the active molecules are encapsulated in a shield to deliver them safely and at the desired potency. This process makes Shoden active even at a low dosage.

Arjuna is supporting several ongoing clinical studies of Shoden that already have yielded promising results of the ingredient for alleviating depression, stress, and sleep disturbances, and for improving immunomodulation and production of testosterone.



Like this story? Subscribe to Nutraceutical Business Review magazine for incisive analysis, the latest news and expert-written articles from the functional food and drink industries. For more information click here.

Companies